16.1 C
Delhi
Saturday, January 28, 2023

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

Sri Lanka to cut down on 1/3rd army to save its economy

The crisis in Sri Lanka, which is under China’s debt, does not seem to have an end. Inflation...

Powerful Scorpene-class submarine engine to charge battery quickly during secret missions

The Indian Navy getting the 5th submarine from the Scorpene-class is highly crucial because at this point in...

Kim Jong sleuths operating network from South Korean prisons, planning coup

North Korean dictator Kim Jong Un has prepared a double-cross intrigue to overthrow the democratic government of South...

Country’s first Jain knowledge repository in Nasik, scriptures to be preserved

The construction work of the country’s first Jain knowledge repository, which will be stronger than concrete and will...